Stonebridge Capital Management Inc Gilead Sciences, Inc. Transaction History

Stonebridge Capital Management Inc

$224 Million
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 01, 2022	SELL	$57.72 - $65.01 $1.85 Million - $2.09 Million	-32,123 Closed	0 $0
Q1 2022 Apr 04, 2022	SELL	$57.92 - $72.58 $20,272 - $25,403	-350 Reduced 1.08%	32,123 $1.91 Million
Q4 2021 Jan 05, 2022	SELL	$64.88 - $73.64 $188,152 - $213,556	-2,900 Reduced 8.2%	32,473 $2.36 Million
Q3 2021 Oct 07, 2021	SELL	$67.69 - $73.03 $46,706 - $50,390	-690 Reduced 1.91%	35,373 $2.47 Million
Q2 2021 Jul 06, 2021	BUY	$63.47 - $69.35 $12,694 - $13,869	200 Added 0.56%	36,063 $2.48 Million

Q1 2021 Apr 05, 2021	BUY	$60.0 - $68.46 $78,000 - $88,997	1,300 Added 3.76%	35,863 $2.32 Million
Q4 2020 Jan 06, 2021	SELL	$56.65 - $64.55 $4,078 - $4,647	-72 Reduced 0.21%	34,563 $2.01 Million
Q3 2020 Dec 11, 2020	BUY	$62.1 - $78.08 $388,435 - $488,390	6,255 Added 22.04%	34,635 $2.19 Million
Q2 2020 Jul 07, 2020	SELL	$72.34 - $84.0 $164,067 - $190,512	-2,268 Reduced 7.4%	28,380 $2.16 Million
Q1 2020 May 20, 2020	SELL	$62.63 - $80.22 $112,734 - $144,396	-1,800 Reduced 5.55%	30,648 $2.29 Million
Q4 2019 Jan 02, 2020	SELL	$61.62 - $67.78 $390,362 - $429,386	-6,335 Reduced 16.33%	32,448 $2.11 Million
Q3 2019 Oct 02, 2019	SELL	$62.51 - $69.0 $966,092 - $1.07 Million	-15,455 Reduced 28.49%	38,783 $2.46 Million
Q2 2019 Jul 12, 2019	SELL	$61.87 - $69.38 $1.38 Million - $1.55 Million	-22,319 Reduced 29.15%	54,238 $3.66 Million
Q1 2019 May 02, 2019	BUY	$62.53 - $70.05 $414,323 - $464,151	6,626 Added 9.48%	76,557 $4.98 Million
Q4 2018 Jan 25, 2019	BUY	$60.54 - $79.0 $505,872 - $660,124	8,356 Added 13.57%	69,931 $4.38 Million
Q3 2018 Oct 17, 2018	SELL	$71.28 - $78.92 $70,210 - $77,736	-985 Reduced 1.57%	61,575 $4.75 Million
Q2 2018 Jul 06, 2018	BUY	$64.88 - $75.68 $753,581 - $879,023	11,615 Added 22.8%	62,560 $4.56 Million
Q1 2018 Apr 16, 2018	SELL	$72.84 - $88.8 $198,853 - $242,424	-2,730 Reduced 5.09%	50,945 $3.83 Million
Q4 2017 Jan 29, 2018	BUY	$71.15 - $83.52 $3.82 Million - $4.48 Million	53,675	53,675 $4.24 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

Black Rock Inc. New York, NY

123M
Shares

$8.16 Billion
0.21% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$7.64 Billion
0.17% of portfolio
Capital World Investors Los Angeles, CA

84.5M
Shares

$5.63 Billion
1.06% of portfolio
Capital Research Global Investors Los Angeles, CA

61.2M
Shares

$4.08 Billion
1.05% of portfolio
State Street Corp Boston, MA

57.7M
Shares

$3.84 Billion
0.19% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Management Inc with notifications on news.

Account